Manja Boerman has an estimated net worth of $1.32 Million. This is based on reported shares in Catalent, Inc.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with ...

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ...

Manja Boerman tapped as president of Cell & Gene Therapy for Catalent with retirement of Pete Buzy. Catalent announced several leadership changes in its cell and gene therapy business in an April 30, ...

Cambridge, UK, 8 July 2025 – 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform, announces the appointment ...

Catalent opened a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European Center of Excellence for Cell Therapies in Gosselies, Belgium. The facility, which contains over 12,000 ...

Cambridge, UK, 8 July 2025 - 4basebio PLC (AIM: 4BB), an innovation-led provider of novel synthetic DNA products and a non-viral, thermostable nucleic acid delivery platform, announces the appointment ...